Zoecare: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Zoecare
Largest movements
- Receivables within one year -€11,500
down €11,500 (-17.3%), from €66,514 to €55,013
of which Trade receivables: -€17,267
- Cash -€2,751
down €2,751 (-18.3%), from €14,998 to €12,247
mainly Current portion of long-term debt (-€20,272) and Trade debts (-€53)
- Current portion of long-term debt -€20,272
no longer reported in 2025 (was €20,272)
- Profit (loss) carried forward +€6,073
up €6,073 (+9.5%), from €63,748 to €69,821
- Taxes -€12,475
no longer reported in 2025 (was €12,475)
- Staff costs +€5,258
new in 2025: €5,258
- Other operating charges +€1,318
up €1,318 (+372.0%), from €354 to €1,672
- Financial charges +€215
up €215 (+13.5%), from €1,584 to €1,799
- Provisions -€165
no longer reported in 2025 (was €165)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €93,612 | €79,360 | -€14,251 | -15.2% |
| Current assets | 29/58 | €93,612 | €79,360 | -€14,251 | -15.2% |
| Stocks and contracts in progress | 3 | €12,100 | €12,100 | = | 0.0% |
| Stocks | 30/36 | €12,100 | €12,100 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €66,514 | €55,013 | -€11,500 | -17.3% |
| Trade receivables | 40 | €55,105 | €37,838 | -€17,267 | -31.3% |
| Other amounts receivable | 41 | €11,409 | €17,175 | +€5,766 | +50.5% |
| Cash at bank and in hand | 54/58 | €14,998 | €12,247 | -€2,751 | -18.3% |
| Total equity and liabilities | 10/49 | €93,612 | €79,360 | -€14,251 | -15.2% |
| Equity | 10/15 | €71,567 | €77,641 | +€6,073 | +8.5% |
| Contributions | 10/11 | €3,100 | €3,100 | = | 0.0% |
| Outside capital | 11 | €3,100 | €3,100 | = | 0.0% |
| Share premium | 1100/10 | €3,100 | €3,100 | = | 0.0% |
| Reserves | 13 | €4,720 | €4,720 | = | 0.0% |
| Non-distributable reserves | 130/1 | - | €4,720 | +€4,720 | |
| Legal reserve | 130 | - | €4,720 | +€4,720 | |
| Distributable reserves | 133 | €4,720 | - | -€4,720 | |
| Profit (loss) carried forward | 14 | €63,748 | €69,821 | +€6,073 | +9.5% |
| Amounts payable | 17/49 | €22,044 | €1,720 | -€20,325 | -92.2% |
| Amounts payable after more than one year | 17 | €1,720 | €1,720 | = | 0.0% |
| Financial debts | 170/4 | €1,720 | €1,720 | = | 0.0% |
| Amounts payable within one year | 42/48 | €20,325 | - | -€20,325 | |
| Current portion of amounts payable after more than one year | 42 | €20,272 | - | -€20,272 | |
| Trade debts | 44 | €53 | - | -€53 | |
| Suppliers | 440/4 | €53 | - | -€53 | |
| Remuneration, social security and pensions | 62 | - | €5,258 | +€5,258 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €165 | - | -€165 | |
| Other operating charges | 640/8 | €354 | €1,672 | +€1,318 | +372.0% |
| Gross operating margin | 9900 | €14,775 | €14,803 | +€28 | +0.2% |
| Operating profit (loss) | 9901 | €14,255 | €7,872 | -€6,383 | -44.8% |
| Financial charges | 65/66B | €1,584 | €1,799 | +€215 | +13.5% |
| Recurring financial charges | 65 | €1,584 | €1,799 | +€215 | +13.5% |
| Profit (loss) for the period before taxes | 9903 | €12,671 | €6,073 | -€6,598 | -52.1% |
| Income taxes | 67/77 | €12,475 | - | -€12,475 | |
| Profit (loss) for the period | 9904 | €196 | €6,073 | +€5,878 | +3000.7% |
| Profit (loss) for the period to be appropriated | 9905 | €196 | €6,073 | +€5,878 | +3000.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.